Try our beta test site

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2002 by Triangle Pharmaceuticals.
Recruitment status was:  Active, not recruiting
Information provided by:
Triangle Pharmaceuticals Identifier:
First received: August 20, 2002
Last updated: June 23, 2005
Last verified: November 2002
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Study Completion Date: No date given
  Primary Completion Date: No date given